Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine whether 18F-Al labeled RGD is safety and effective for cancer diagnosis and therapy response.

Clinical Trial Description

Observe radiation dose to healthy volunteers and patients; the correlation between integrin level and tumor/metastases uptake. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02441972
Study type	Interventional
Source	Wuxi No. 4 People's Hospital
Contact	Chunjing Yu, Dr.
Phone	86-15312238622
Email	ycj_wxd1978@163.com
Status	Recruiting
Phase	Phase 1
Start date	January 2012
Completion date	December 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04996316` - MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals
Enrolling by invitation	`NCT05558917` - Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery	N/A
Completed	`NCT05526872` - A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening	N/A
Not yet recruiting	`NCT05178498` - Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Recruiting	`NCT05544123` - The Treatment Situation of Chinese County Population With Breast Cancer
Withdrawn	`NCT05191004` - Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC	Phase 1/Phase 2
Terminated	`NCT02890368` - Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides	Phase 1
Recruiting	`NCT01462903` - A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors	Phase 1
Completed	`NCT01422408` - Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy	Phase 2
Terminated	`NCT02810873` - Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer	N/A
Terminated	`NCT00770354` - Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer	Phase 2
Withdrawn	`NCT03185871` - Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses	Phase 2
Completed	`NCT02983279` - Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer	N/A
Active, not recruiting	`NCT02194387` - Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members	N/A
Recruiting	`NCT05406232` - Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
Recruiting	`NCT03408353` - Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
Completed	`NCT01641068` - Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms	N/A
Withdrawn	`NCT04190433` - Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial	Phase 2
Recruiting	`NCT04799535` - Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Terminated	`NCT02923037` - Hatha Yoga in Breast Cancer Survivors	N/A